BG Medical Technologies Launches Corporate Website for Medical Marijuana Investors
Leading medical cannabis company creates gateway for corporate insight and investment information
LOS ANGELES, Feb. 22, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) has launched a new website for investors, shareholders, and individuals interested in the company products and services strategy as it relates to the medical marijuana industry. At www.BGMedTech.com investors are provided information to bridge the gap between media coverage and the true effects of news on the medical marijuana industry. BG Medical has also released its forward-looking vision for projected company innovations leading up to and beyond 2015.
Key features of the site include BG Medical's product strategy overview, product information, timely and educational market commentary, press history, and a forthcoming full-featured investor relations area.
"As industry insiders we recognize there has too often been a muddied wall between cannabis shareholders and the companies they are investing into," states Angel Stanz, CEO. "We're raising the bar by increasing communication and transparency by offering a deeper level of due diligence into our product development progress and corporate culture with frequent updates and immediately relevant content."
BGMedTech.com is introduced today with a base level of content as a welcoming introduction to its new visitors. Additional content will be added daily in the upcoming weeks. Parties interested in being the first to be notified of new content are invited to contribute Twitter and electronic contact information.
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana testing laboratory and website portal, BudGenius.com. BG Medical does not sell, grow, harvest, cultivate, nor distribute medical cannabis. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
[email protected]
(855) 723-3283
SOURCE BG Medical Technologies, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article